A subset of 25% demonstrated quick recovery from the initial neutropenia, whereas 23% of patients displayed an aplastic phenotype characterized by a protracted course of neutropenia despite G-CSF use (139). The gene discussed is CSF3; the disease is Decreased total neutrophil count.